A Universal Screening Strategy for SARS-CoV-2 Infection in Intensive Care Units: Korean Experience in a Single Hospital

다국어 초록 (Multilingual Abstract)

Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is not differentiated clinically from other respiratory infections, and intensive care units (ICUs) are vulnerable to in-hospital transmission due to interventions inducing respiratory aerosols.
This study evaluated the effectiveness of universal SARS-CoV-2 screening in ICUs in terms of screened-out cases and reduction in anxiety of healthcare personnel (HCP).
Materials and Methods: This prospective single-armed observational study was conducted in 2 ICUs of a single hospital. The number of patients diagnosed with SARS-CoV-2 infection by the screening program and healthcare workers in ICUs that visited the SARS-CoV-2 screening clinic or infection clinic were investigated.
Results: During the 7-week study period, no positive screening case was reported among a total of 142 patients. Among 86 HCP in the ICUs, only 2 HCP sought medical consultation for SARS-CoV-2 infection during the initial 2 weeks.
Conclusion: A universal screening program for SARS-CoV-2 infection in ICUs with the coordination of other countermeasures in the hospital was reasonably effective in preventing in-hospital transmission in a pandemic situation and making clinical practices and HCP stable.

참고문헌 (Reference)

1 Sutton D, "Universal screening for SARS-CoV-2 in women admitted for delivery" 382 : 2163-2164, 2020

2 Rothe C, "Transmission of 2019-nCoV infection from an asymptomatic contact in Germany" 382 : 970-971, 2020

3 Wu D, "The SARS-CoV-2 outbreak : what we know" 94 : 44-48, 2020

4 Al-Shamsi HO, "Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates" 2020

5 Zou L, "SARS-CoV-2 viral load in upper respiratory specimens of infected patients" 382 : 1177-1179, 2020

6 Svoboda T, "Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto" 350 : 2352-2361, 2004

7 Centers for Disease Control and Prevention (CDC), "Interim U.S. guidance for risk assessment and public health management of healthcare personnel with potential exposure in a healthcare setting to patients with 2019 novel coronavirus (2019-nCoV)"

8 Puiu T, "How long will the coronavirus pandemic last?"

9 Koo Bo Kyung, "Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening" 대한감염학회 52 (52): 219-221, 2020

10 Hunter E, "First experience of COVID-19 screening of health-care workers in England" 395 : e77-e78, 2020

11 Li Q, "Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia" 382 : 1199-1207, 2020

12 Zhan M, "Death from Covid-19 of 23 health care workers in China" 382 : 2267-2268, 2020

13 Weiss P, "Clinical course and mortality risk of severe COVID-19" 395 : 1014-1015, 2020

14 Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China" 382 : 1708-1720, 2020